Naomi Fried, PhD, is the founder and CEO of PharmStars, the first pharma-focused accelerator for digital health startups. She is also a Managing Partner and co-founder at Ambit Health Ventures, a VC fund focused on early-stage digital health investments.
Previously, Naomi was the CEO of the boutique advisory firm, Health Innovation Strategies, which assisted large healthcare organizations with innovation program design and optimization, digital health strategy, and innovation activities. Naomi was the first VP of Innovation and External Partnerships at Biogen where she developed the firm’s “innovation beyond the molecule strategy.” Prior to that, she was the first Chief Innovation Officer at Boston Children’s Hospital, where she built and led a team to promote digital health and clinical innovation. Prior to that, she was the first VP of Innovation and Advanced Technology at Kaiser Permanente where she led an effort to identify and assess new and emerging health care technology. Naomi is on the board of Wavely Diagnostics and has served on the board of Directors of the American Telemedicine Association and was a member of the Governor of Massachusetts’ Innovation Council.
Naomi received her PhD in Materials Science from MIT and her BS in Chemistry from the University of California, Berkeley.